1-(4-methoxyphenyl)pyridinium has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 24 studies
| Studies (1-(4-methoxyphenyl)pyridinium) | Trials (1-(4-methoxyphenyl)pyridinium) | Recent Studies (post-2010) (1-(4-methoxyphenyl)pyridinium) | Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) |
|---|---|---|---|---|---|
| 55 | 0 | 1 | 3,859 | 8 | 1,052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 15 (62.50) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiueh, CC; Obata, T | 1 |
| Campbell, KJ; Hattori, T; Takada, M | 1 |
| Hanani, M | 1 |
| Lange, KW | 1 |
| Crampton, JM; Lau, YS; Trobough, KL; Wilson, JA | 1 |
| Chiba, K; Horii, H; Ishizaki, T; Kato, Y; Kubota, E | 1 |
| Fukui, Y; Nagatsu, T; Naoi, M; Ohashi, M; Takahashi, T; Umemura, T; Yasue, T | 1 |
| López Alemany, M | 1 |
| Cohen, G; Heikkila, RE; Mytilineou, C | 1 |
| Cesura, AM; Da Prada, M; Haefely, WE; Kettler, R; Zürcher, G | 1 |
| Hirata, Y; Nagatsu, T | 1 |
| Forno, LS; Irwin, I; Langston, EB; Langston, JW | 1 |
| Chang, FW; Lee, EH; Lu, KT; Wang, SD | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, E; Miele, M; Migheli, R | 1 |
| Mizuno, Y; Mochizuki, H; Nakamura, N; Nishi, K | 1 |
| Otto, D; Unsicker, K | 1 |
| Del Zompo, M; Gessa, GL; Piccardi, MP; Quartu, M; Ruiu, S; Vaccari, A | 1 |
| Hasegawa, E; Murai, Y; Oishi, T | 1 |
| May, T | 1 |
| Bagchi, SP | 1 |
| Baudry, M; Fonck, C | 1 |
| Ho, LT; Lay, YP; Lin, AM; Liu, TY; Luh, TY; Ueng, YF; Yang, CH | 1 |
| Drobitch, R; Hagg, T; Robertson, H; Van Kampen, J | 1 |
| Guerra, MJ; Labandeira-Garcia, JL; Mendez-Alvarez, E; Muñoz, A; Rey, P; Soto-Otero, R | 1 |
24 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dialysis; Dopamine; Free Radicals; Hydroxides; Hydroxyl Radical; Male; Nerve Endings; Perfusion; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Salicylic Acid; Substantia Nigra | 1992 |
Regional localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) uptake: mismatch between its uptake and neurotoxic sites.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Injections, Intraventricular; Male; Mesencephalon; Motor Neurons; Pargyline; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Cholinergic | 1991 |
Rapid effects of MPTP in the mouse colon.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic beta-Antagonists; Animals; Colon; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Neurotransmitter Agents; Pyridinium Compounds; Receptors, Cholinergic; Reserpine; Tyramine | 1990 |
Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Behavior, Animal; Injections; Male; MPTP Poisoning; Nervous System Diseases; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1990 |
Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Male; Mice; Mice, Inbred C57BL; Probenecid; Pyridinium Compounds | 1990 |
Effects of N-methylmercaptoimidazole on the disposition of MPTP and its metabolites in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biotransformation; Cerebral Cortex; Corpus Striatum; Half-Life; Male; Methimazole; Mice; Mixed Function Oxygenases; Pyridinium Compounds | 1990 |
Cytotoxic effect of 1-methyl-4-phenylpyridinium ion on human melanoma cell lines, HMV-II and SK-MEL-44, is dependent on the melanin contents and caused by inhibition of mitochondrial electron transport.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Cell Line; Cell Survival; Colony-Forming Units Assay; Electron Transport; Formazans; Humans; Melanins; Melanoma; Mitochondria; MPTP Poisoning; Oxidation-Reduction; Pyridinium Compounds; Tumor Cells, Cultured | 1990 |
Parkinsonism as late toxic effect of dihydropyridines?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Humans; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Time Factors | 1986 |
1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Culture Techniques; Dopamine; Homovanillic Acid; Mesencephalon; Microscopy, Fluorescence; Organ Specificity; Pyridines; Pyridinium Compounds; Rats | 1985 |
Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Blood Platelets; Humans; In Vitro Techniques; Isoenzymes; Monoamine Oxidase; Oxidation-Reduction; Pyridines; Pyridinium Compounds; Serotonin | 1985 |
Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dihydroxyphenylalanine; Hydroxylation; In Vitro Techniques; Male; Monoamine Oxidase; Pargyline; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tyrosine | 1985 |
Pargyline prevents MPTP-induced parkinsonism in primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Chemistry; Male; Neurons; Pargyline; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Saimiri; Substantia Nigra | 1984 |
Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Blotting, Western; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dopamine beta-Hydroxylase; Electrophoresis, Polyacrylamide Gel; Glial Fibrillary Acidic Protein; Gliotoxin; Indicators and Reagents; Locus Coeruleus; Male; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Neurons; Norepinephrine; Pyridinium Compounds; Spectrometry, Fluorescence; Stereotaxic Techniques; Substantia Nigra; Tyrosine 3-Monooxygenase | 1993 |
Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Glutathione; Male; MPTP Poisoning; Nerve Endings; Oxidation-Reduction; Pyridinium Compounds; Rats; Rats, Wistar; Synaptosomes; Uric Acid | 1993 |
Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; DNA; DNA Nucleotidylexotransferase; Electrophoresis, Agar Gel; Immunohistochemistry; Mesencephalon; Neostriatum; Organ Culture Techniques; Pyridinium Compounds; Rats; Spectrophotometry, Ultraviolet | 1994 |
FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Astrocytes; Cells, Cultured; Dopamine; Dopamine Agents; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor 2; Glial Fibrillary Acidic Protein; Immunohistochemistry; Mesencephalon; MPTP Poisoning; Neurites; Neurofilament Proteins; Neurons; Pregnancy; Pyridinium Compounds; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 1993 |
Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Biomarkers; Brain; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Male; Mice; Microscopy, Electron; MPTP Poisoning; Nervous System Diseases; Pyridinium Compounds; Synaptic Vesicles; Tetrabenazine | 1993 |
Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Cysteamine; Dimercaprol; Dopamine; Dopamine Agents; Glutathione; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Nervous System Diseases; Pyridinium Compounds; Sulfhydryl Compounds | 1993 |
1-Methyl-4-phenylpyridinium (MPP+) binds with high affinity to a beta-carboline binding site located on monoamine oxidase type A in rat brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Brain; Carbolines; Cerebral Cortex; Harmine; Male; Monoamine Oxidase; Pargyline; Pyridinium Compounds; Rats; Rats, Wistar | 1993 |
Striatal and urinary DOPAC/DA ratio may indicate a long-lasting DA release enhancement by MPP+ and MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Mice; Mice, Inbred C57BL; Pyridinium Compounds; Reserpine; Synaptosomes | 1998 |
Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Antioxidants; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cyclic N-Oxides; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Free Radicals; In Vitro Techniques; Male; Mazindol; Mitochondria; Neostriatum; Nitrogen Oxides; Organometallic Compounds; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Rotenone; Salicylates; Subcellular Fractions; Synaptosomes; Uncoupling Agents | 2003 |
Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Axons; Blotting, Western; Carboxylic Acids; Cytochrome c Group; Cytochrome P-450 Enzyme System; Cytosol; Dopamine; Dopamine Agents; Electrochemistry; Fullerenes; Lipid Peroxidation; Liver; Male; Mice; Microinjections; Neostriatum; Oxidative Stress; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2004 |
Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Locomotion; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Panax; Parkinson Disease, Secondary; Phytotherapy; Plant Extracts; Pyridinium Compounds; Rats; Rats, Sprague-Dawley | 2003 |
Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiparkinson Agents; Captopril; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; In Vitro Techniques; Lipid Peroxidation; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Neostriatum; Nerve Degeneration; Nerve Endings; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Pyridinium Compounds; Synaptosomes; Tyrosine 3-Monooxygenase | 2006 |